Paperpal Prime Logo

Journal of the Egyptian National Cancer Institute : Impact Factor & More

eISSN: 2589-0409pISSN: 1110-0362
JournalOpen Access

Key Metrics

CiteScore
2.1
H-Index
26
SJR
Q3Oncology
SNIP
0.67
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of the Egyptian National Cancer Institute

Journal of the Egyptian National Cancer Institute Journal Specifications

Overview
Publisher SPRINGER
Language English
Frequency Continuous publication
Publication Time11
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorCairo University, National Cancer Institute
FrequencyContinuous publication
Publication Start Year2011
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 11
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Journal of the Egyptian National Cancer Institute ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of the Egyptian National Cancer Institute

Bidirectional mendelian randomization identifies plasma proteins associated with cervical cancer risk.
  • 1 Jul 2026
  • Journal of the Egyptian National Cancer Institute
Decoding the functional landscape of long non-coding RNAs in hepatocellular carcinoma: molecular mechanisms, clinical implications, and therapeutic prospects.
  • 29 Jun 2026
  • Journal of the Egyptian National Cancer Institute
Navigating toxicity in lung cancer immunotherapy: challenges and advances in Nano medicine drug delivery.
  • 29 Jun 2026
  • Journal of the Egyptian National Cancer Institute
Tissue engineering driven regeneration in oral squamous cell carcinoma: from biomaterials to precision gene editing.
  • 22 Jun 2026
  • Journal of the Egyptian National Cancer Institute
Metabolic and nutritional impact of gastrectomy and perioperative treatment in gastric cancer: a prospective cohort study.
  • 22 Jun 2026
  • Journal of the Egyptian National Cancer Institute
Metformin enhances methylene blue-mediated photodynamic therapy in oral squamous cell carcinoma.
  • 22 Jun 2026
  • Journal of the Egyptian National Cancer Institute
Bidirectional mendelian randomization identifies plasma proteins associated with cervical cancer risk.
  • 1 Jul 2026
  • Journal of the Egyptian National Cancer Institute
Decoding the functional landscape of long non-coding RNAs in hepatocellular carcinoma: molecular mechanisms, clinical implications, and therapeutic prospects.
  • 29 Jun 2026
  • Journal of the Egyptian National Cancer Institute
Navigating toxicity in lung cancer immunotherapy: challenges and advances in Nano medicine drug delivery.
  • 29 Jun 2026
  • Journal of the Egyptian National Cancer Institute
Tissue engineering driven regeneration in oral squamous cell carcinoma: from biomaterials to precision gene editing.
  • 22 Jun 2026
  • Journal of the Egyptian National Cancer Institute
Metabolic and nutritional impact of gastrectomy and perioperative treatment in gastric cancer: a prospective cohort study.
  • 22 Jun 2026
  • Journal of the Egyptian National Cancer Institute
Metformin enhances methylene blue-mediated photodynamic therapy in oral squamous cell carcinoma.
  • 22 Jun 2026
  • Journal of the Egyptian National Cancer Institute

FAQs on Journal of the Egyptian National Cancer Institute